{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:35:14Z","timestamp":1786120514930,"version":"build-2736575974"},"reference-count":125,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001009","name":"Bristol Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jmig.2025.12.021","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:20:43Z","timestamp":1765988443000},"page":"1001-1013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"Olivia","family":"Mihulka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2380-5681","authenticated-orcid":false,"given":"Raksha M.","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-176X","authenticated-orcid":false,"given":"Kristin E.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2025.12.021_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191911921","article-title":"Sexual dysfunction in women with cancer: a systematic review of longitudinal studies","volume":"19","author":"Sousa Rodrigues Guedes","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jmig.2025.12.021_bib0002","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jsxm.2016.08.011","article-title":"Sexual satisfaction and the importance of sexual health to quality of life throughout the life course of U.S. adults","volume":"13","author":"Flynn","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0003","first-page":"51","article-title":"Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study","volume":"31","author":"Chang","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0004","first-page":"e7586","article-title":"The genitourinary syndrome of menopause: an overview of the recent data","volume":"12","author":"Angelou","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jmig.2025.12.021_bib0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/gme.0b013e31825a27ab","article-title":"Oophorectomy: the debate between ovarian conservation and elective oophorectomy","volume":"20","author":"Erekson","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0006","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ygyno.2015.11.010","article-title":"Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide","volume":"140","author":"Huffman","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0360-3016(93)90455-5","article-title":"Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma","volume":"27","author":"Bruner","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jmig.2025.12.021_bib0008","first-page":"1177","article-title":"Sexual dysfunction in females after cancer treatment: an unresolved issue","volume":"18","author":"Shankar","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jmig.2025.12.021_bib0009","first-page":"1171","article-title":"Incidence and severity of sexual dysfunction among women with breast cancer: a meta-analysis based on female sexual function index","volume":"27","author":"Jing","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/09513590.2018.1467401","article-title":"The sex life of women surviving breast cancer","volume":"34","author":"Ghizzani","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0011","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1245\/s10434-017-5905-4","article-title":"Breast-specific sensuality and sexual function in cancer survivorship: does surgical modality matter?","volume":"24","author":"Gass","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0012","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/pon.3130","article-title":"Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy","volume":"22","author":"Safarinejad","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.jmig.2025.12.021_bib0013","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/COC.0000000000000552","article-title":"Sexual dysfunction in breast cancer survivors: is it surgical modality or adjuvant therapy?","volume":"42","author":"Gandhi","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0014","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-023-06953-9","article-title":"Breast cancer survivorship and sexual dysfunction: a population-based cohort study","volume":"200","author":"Chang","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jmig.2025.12.021_bib0015","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1245\/s10434-014-3483-2","article-title":"Implant breast reconstruction and radiation: a multicenter analysis of long-term health-related quality of life and satisfaction","volume":"21","author":"Albornoz","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0016","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0017","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1200\/JCO.22.01885","article-title":"Cancer treatment-related ovarian dysfunction in women of childbearing potential: management and fertility preservation options","volume":"41","author":"Reynolds","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0018","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.3390\/jcm11226723","article-title":"Sexual health after a breast cancer diagnosis: addressing a forgotten aspect of survivorship","volume":"11","author":"Vegunta","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0019","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5694\/mja16.00947","article-title":"Supportive care of women with breast cancer: key concerns and practical solutions","volume":"205","author":"Zdenkowski","year":"2016","journal-title":"Med J Aust"},{"key":"10.1016\/j.jmig.2025.12.021_bib0020","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1200\/JCO.2001.19.11.2788","article-title":"Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study","volume":"19","author":"Berglund","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0021","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","article-title":"Managing menopause after cancer","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jmig.2025.12.021_bib0022","first-page":"Doc08","article-title":"Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy","volume":"21","author":"Reimer","year":"2023","journal-title":"Ger Med Sci"},{"key":"10.1016\/j.jmig.2025.12.021_bib0023","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jsxm.2017.08.004","article-title":"Factors associated with specific DSM-IV sexual dysfunctions in breast cancer survivors: a study of patients and their partners","volume":"14","author":"Hummel","year":"2017","journal-title":"J Sex Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0024","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/gme.0b013e3181aac32b","article-title":"Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study","volume":"16","author":"Dorjgochoo","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0025","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1056\/NEJMra1307118","article-title":"Systemic therapy for estrogen receptor\u2013positive, HER2-negative breast cancer","volume":"383","author":"Spring","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0026","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/GME.0b013e31829e41df","article-title":"Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors","volume":"21","author":"Kallak","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0027","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1111\/jsm.12684","article-title":"Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors","volume":"11","author":"Schover","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0028","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1245\/s10434-019-07552-z","article-title":"Sexual dysfunction in survivorship; the impact of menopause and endocrine therapy","volume":"26","author":"Kuehn","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0029","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/GME.0b013e31826560da","article-title":"Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer","volume":"20","author":"Baumgart","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.844926","article-title":"Hot flushes and sweating, sleep problems, joint and muscular discomfort, and physical and mental exhaustion in breast cancer survivors during the first 24 months of tamoxifen therapy: a prospective observational study","volume":"12","author":"Sung","year":"2022","journal-title":"Front Oncol"},{"issue":"25","key":"10.1016\/j.jmig.2025.12.021_bib0031","first-page":"262","article-title":"Female sexual function, dysfunction, and treatment: a biopsychosocial multidisciplinary approach","volume":"S1553-4650","author":"Myers","year":"2025","journal-title":"J Minim Invasive Gynecol"},{"issue":"25","key":"10.1016\/j.jmig.2025.12.021_bib0032","first-page":"00202","article-title":"Female sexual desire, arousal, and orgasmic dysfunctions: a systematic review and meta-analysis of treatment options","volume":"S1553-4650","author":"Toledo","year":"2025","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0033","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","article-title":"Vaginal estrogen therapy use and survival in females with breast cancer","volume":"10","author":"McVicker","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0034","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/AOG.0000000000005294","article-title":"Safety of vaginal estrogen therapy for genitourinary syndrome of menopause in women with a history of breast cancer","volume":"142","author":"Agrawal","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40695-015-0009-4","article-title":"Management of sexual dysfunction in breast cancer survivors: a systematic review","volume":"1","author":"Seav","year":"2015","journal-title":"Womens Midlife Health"},{"key":"10.1016\/j.jmig.2025.12.021_bib0036","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1997.15.3.969","article-title":"Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer","volume":"15","author":"Loprinzi","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0037","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00192-020-04282-9","article-title":"Local treatment with a polycarbophil-based cream in postmenopausal women with genitourinary syndrome of menopause","volume":"32","author":"Yodplob","year":"2021","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jmig.2025.12.021_bib0038","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/GME.0000000000002390","article-title":"A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause","volume":"31","author":"Agrawal","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0039","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2017.75.8995","article-title":"Interventions to address sexual problems in people with cancer: ASCO clinical practice guideline adaptation of cancer care Ontario guideline","volume":"36","author":"Carter","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/jmf.2006.1209","article-title":"In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria","volume":"10","author":"Ogbolu","year":"2007","journal-title":"J Med Food"},{"key":"10.1016\/j.jmig.2025.12.021_bib0041","first-page":"1","article-title":"Antimicrobial potential of Cocos nucifera (coconut) oil on bacterial isolates","volume":"1476","author":"Bhardwaj","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0042","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/13697137.2015.1124259","article-title":"Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?","volume":"19","author":"Edwards","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.jmig.2025.12.021_bib0043","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-016-3865-1","article-title":"A randomized, double-blind, crossover trial comparing a silicone- versus water-based lubricant for sexual discomfort after breast cancer","volume":"158","author":"Hickey","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jmig.2025.12.021_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jmig.2025.12.021_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5306\/wjco.v13.i2.71","article-title":"Management of genitourinary syndrome of menopause in breast cancer survivors: an update","volume":"13","author":"Lubi\u00e1n L\u00f3pez","year":"2022","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0046","first-page":"1325","article-title":"The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer","volume":"27","author":"Keshavarzi","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0047","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.3390\/molecules28186605","article-title":"Effect of vitamin D on the proliferation and barrier of atrophic vaginal epithelial cells","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jmig.2025.12.021_bib0048","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ijgo.70011","article-title":"The effectiveness of vitamin D as an alternative to FDA-approved treatment and other therapies for managing vulvovaginal atrophy and sexual inactivity in postmenopausal women: a systematic review and meta-analysis","volume":"170","author":"Youssef","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jmig.2025.12.021_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1402389","article-title":"Associations of vaginal microbiota with the onset, severity, and type of symptoms of genitourinary syndrome of menopause in women","volume":"14","author":"Zeng","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12885-021-08274-w","article-title":"Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial","volume":"21","author":"Martins","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0051","unstructured":"National Comprehensive Cancer Network. Survivorship (version 2.2025). NCCN Clinical Practice Guidelines in Oncology. 2025. Accessed November 25, 2025. https:\/\/www.nccn.org"},{"key":"10.1016\/j.jmig.2025.12.021_bib0052","unstructured":"National Comprehensive Cancer Network. Uterine neoplasms (version 1.2025). NCCN Clinical Practice Guidelines in Oncology. 2025. Accessed November 25, 2025. https:\/\/www.nccn.org"},{"key":"10.1016\/j.jmig.2025.12.021_bib0053","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2020.01.005","article-title":"European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis","volume":"134","author":"Rees","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2025.12.021_bib0054","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2020.01.035","article-title":"Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: a Society of Gynecologic Oncology (SGO) clinical practice statement","volume":"157","author":"Sinno","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0055","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/jcm13051443","article-title":"Hormone replacement therapy in post-menopause hormone-dependent gynecological cancer patients: a narrative review","volume":"13","author":"Villa","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0056","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/GME.0000000000001497","volume":"27","author":"Hirschberg","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0057","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jnci\/djac112","article-title":"Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study","volume":"114","author":"Cold","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2025.12.021_bib0058","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.2010-0435","article-title":"Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I\/II study","volume":"16","author":"Witherby","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.jmig.2025.12.021_bib0059","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2018-01345","article-title":"Intravaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors","volume":"103","author":"Davis","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmig.2025.12.021_bib0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamaoncol.2016.3904","article-title":"Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial","volume":"3","author":"Melisko","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0061","series-title":"INTRAROSA (Prasterone) Vaginal Inserts","year":"2016"},{"key":"10.1016\/j.jmig.2025.12.021_bib0062","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2007.02.007","article-title":"Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women","volume":"107","author":"Labrie","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0063","first-page":"1335","article-title":"Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)","volume":"26","author":"Barton","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0064","first-page":"643","article-title":"Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)","volume":"26","author":"Barton","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/13697137.2022.2050208","article-title":"Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study","volume":"25","author":"Mension","year":"2022","journal-title":"Climacteric"},{"key":"10.1016\/j.jmig.2025.12.021_bib0066","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.maturitas.2012.12.002","article-title":"Ospemifene, vulvovaginal atrophy, and breast cancer","volume":"74","author":"Wurz","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2025.12.021_bib0067","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1080\/14656566.2024.2391009","article-title":"Ospemifene and vulvovaginal atrophy: an update of the clinical profile for post-menopausal women","volume":"25","author":"Di Carlo","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jmig.2025.12.021_bib0068","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0069","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13697130903305627","article-title":"Effects of bazedoxifene\/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar\/vaginal atrophy","volume":"13","author":"Bachmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jmig.2025.12.021_bib0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0071","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/ijc.31267","article-title":"Tibolone and risk of gynecological hormone sensitive cancer","volume":"142","author":"L\u00f8kkegaard","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0072","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.maturitas.2006.03.012","article-title":"Endometrial cancer patients and tibolone: a matched case-control study","volume":"55","author":"Lee","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2025.12.021_bib0073","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.maturitas.2006.01.010","article-title":"The safety of tibolone in epithelial ovarian cancer patients","volume":"55","author":"Lee","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2025.12.021_bib0074","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41598-019-38759-5","article-title":"Impact of gynecologic cancer on pelvic floor disorder symptoms and quality of life: an observational study","volume":"9","author":"Neron","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmig.2025.12.021_bib0075","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s00192-022-05271-w","article-title":"Prevalence of pelvic floor disorders, associations of endocrine therapy, and surgical intervention among breast cancer survivors","volume":"33","author":"Pennycuff","year":"2022","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jmig.2025.12.021_bib0076","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.prro.2023.10.002","article-title":"Daily vaginal dilator use during radiation for women with squamous cell carcinoma of the anus: vaginal wall dosimetry and patient-reported sexual function","volume":"14","author":"Arzola","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0077","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/NCC.0000000000000500","article-title":"Dilator use after vaginal brachytherapy for endometrial cancer: a randomized feasibility and adherence study","volume":"41","author":"Hanlon","year":"2018","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.jmig.2025.12.021_bib0078","series-title":"How to Use a Vaginal Dilator","year":"2023"},{"key":"10.1016\/j.jmig.2025.12.021_bib0079","series-title":"Vaginal Dilators: A Guide for Health Care Professionals","author":"Langan","year":"2020"},{"key":"10.1016\/j.jmig.2025.12.021_bib0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jpag.2019.05.002","article-title":"Vaginal dilator therapy: a guide for providers for assessing readiness and supporting patients through the process successfully","volume":"32","author":"Amies Oeschlager","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0081","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2017.11.002","article-title":"The International Society for the Study of Women\u2019s Sexual Health process of care for management of hypoactive sexual desire disorder in women","volume":"93","author":"Clayton","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jmig.2025.12.021_bib0082","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2024.05.027","article-title":"Female sexual function in long-term cervical cancer survivors compared with healthy women and women affected by benign gynecological disorders","volume":"299","author":"Garc\u00eda","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192315545","article-title":"Sexual dysfunction among gynaecological cancer survivors: a descriptive cross-sectional study in Malaysia","volume":"19","author":"Mohamad Muhit","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jmig.2025.12.021_bib0084","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jsxm.2021.04.004","article-title":"Physical activity and female sexual dysfunction: a lot helps, but not too much","volume":"18","author":"Maseroli","year":"2021","journal-title":"J Sex Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0085","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/GME.0000000000000824","article-title":"Association of sleep disturbance and sexual function in postmenopausal women","volume":"24","author":"Kling","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2020.103768","article-title":"Effects of a nurse-led positive psychology intervention on sexual function, depression and subjective well-being in postoperative patients with early-stage cervical cancer: a randomized controlled trial","volume":"111","author":"Shi","year":"2020","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.jmig.2025.12.021_bib0087","first-page":"3651","article-title":"Couple-based treatment for sexual problems following breast cancer: a review and synthesis of the literature","volume":"24","author":"Carroll","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0088","first-page":"9117","article-title":"The effect of the EX-PLISSIT model-based psychosexual counseling on improving sexual function and sexual quality of life in gynecologic cancer survivors: a randomized controlled clinical trial","volume":"30","author":"Mohammadi","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0089","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejogrb.2023.09.026","article-title":"Acupuncture modification treatment for female sexual dysfunction: a meta-analysis","volume":"291","author":"Ning","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0090","series-title":"StatPearls","article-title":"Flibanserin","author":"Pierrelus","year":"2025"},{"key":"10.1016\/j.jmig.2025.12.021_bib0091","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038592","article-title":"Role of flibanserin in managing hypoactive sexual desire disorder in women: a systematic review and meta-analysis","volume":"103","author":"Kamrul-Hasan","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jmig.2025.12.021_bib0092","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jsxm.2017.03.258","article-title":"Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study","volume":"14","author":"Portman","year":"2017","journal-title":"J Sex Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0093","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000134","article-title":"Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0094","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1089\/jwh.2016.6230","article-title":"Effect of flibanserin treatment on body weight in premenopausal and postmenopausal women with hypoactive sexual desire disorder: a post hoc analysis","volume":"26","author":"Kornstein","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jmig.2025.12.021_bib0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.sxmr.2019.04.003","article-title":"Weight loss in women taking flibanserin for hypoactive sexual desire disorder (HSDD): insights into potential mechanisms","volume":"7","author":"Simon","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.jmig.2025.12.021_bib0096","series-title":"Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information","year":"2004"},{"key":"10.1016\/j.jmig.2025.12.021_bib0097","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jsxm.2017.11.005","article-title":"Safety of flibanserin in women treated with antidepressants: a randomized, placebo-controlled study","volume":"15","author":"Clayton","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0098","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1060028019899152","article-title":"Bremelanotide: new drug approved for treating hypoactive sexual desire disorder","volume":"54","author":"Mayer","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmig.2025.12.021_bib0099","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/AOG.0000000000003500","article-title":"Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials","volume":"134","author":"Kingsberg","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0100","series-title":"Caring for the Female Cancer Patient: Gynecologic Considerations","first-page":"60","article-title":"Managing sexual health through treatment and survivorship","author":"Moore","year":"2024"},{"key":"10.1016\/j.jmig.2025.12.021_bib0101","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmig.2025.12.021_bib0102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197827","article-title":"Androgen receptor positive triple negative breast cancer: clinicopathologic, prognostic, and predictive features","volume":"13","author":"Astvatsaturyan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jmig.2025.12.021_bib0103","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/AOG.0000000000005395","article-title":"Compounded bioidentical menopausal hormone therapy: ACOG clinical consensus no 6","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0104","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/GME.0000000000001782","article-title":"Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in treating postmenopausal women","volume":"28","author":"Jiang","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GME.0000000000000523","article-title":"Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy","volume":"23","author":"Pinkerton","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0106","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.12788\/j.sder.2018.052","article-title":"Device-based treatment for vaginal wellness","volume":"37","author":"Alexiades","year":"2018","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jmig.2025.12.021_bib0108","series-title":"Statement on Efforts to Safeguard Women\u2019s Health From Deceptive Health Claims and Significant Risks Related to Devices Marketed for Use in Medical Procedures for \u201cVaginal Rejuvenation\u201d","year":"2018"},{"key":"10.1016\/j.jmig.2025.12.021_bib0109","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/lsm.23084","article-title":"Lasers and energy-based devices marketed for vaginal rejuvenation: a cross-sectional analysis of the MAUDE database","volume":"51","author":"Ahluwalia","year":"2019","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/GME.0000000000001293","article-title":"Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy","volume":"26","author":"Gordon","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0111","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/tbj.14211","article-title":"Fractional CO\u2082 vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors","volume":"27","author":"Siliquini","year":"2021","journal-title":"Breast J"},{"key":"10.1016\/j.jmig.2025.12.021_bib0112","doi-asserted-by":"crossref","first-page":"e556","DOI":"10.1016\/j.clbc.2019.04.007","article-title":"The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis","volume":"19","author":"Jha","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0113","first-page":"3669","article-title":"Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors","volume":"28","author":"Quick","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0114","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejogrb.2022.08.012","article-title":"Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: a valid therapeutic choice? A systematic review","volume":"277","author":"D\u2019Oria","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2025.12.021_bib0115","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jama.2021.14892","article-title":"Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial","volume":"326","author":"Li","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2025.12.021_bib0116","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/lsm.23247","article-title":"Fractional Co2 laser treatment of the vulva and vagina and the effect of postmenopausal duration on efficacy","volume":"53","author":"Alexiades","year":"2021","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0117","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/GME.0000000000002465","article-title":"Energy-based interventions for genitourinary syndrome of menopause: a systematic review of randomized controlled trials and prospective observational studies","volume":"32","author":"Zerzan","year":"2025","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2025.12.021_bib0118","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55697","article-title":"Effect of fractional carbon dioxide vs sham laser on sexual function in survivors of breast cancer receiving aromatase inhibitors for genitourinary syndrome of menopause: the LIGHT randomized clinical trial","volume":"6","author":"Mension","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jmig.2025.12.021_bib0119","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.maturitas.2022.07.010","article-title":"Sexual dysfunction in female cancer survivors: addressing the problems and the remedies","volume":"165","author":"Smith","year":"2022","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2025.12.021_bib0120","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s11764-020-00898-4","article-title":"Can the provision of sexual healthcare for oncology patients be improved? A literature review of educational interventions for healthcare professionals","volume":"14","author":"Albers","year":"2020","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.jmig.2025.12.021_bib0121","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1743-6109.2009.01619.x","article-title":"Recommendations for the clinical evaluation of men and women with sexual dysfunction","volume":"7","author":"Hatzichristou","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.jmig.2025.12.021_bib0122","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","article-title":"Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes","volume":"119","author":"Prades","year":"2015","journal-title":"Health Policy"},{"key":"10.1016\/j.jmig.2025.12.021_bib0123","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1002\/cncr.31394","article-title":"Outcomes of multidisciplinary treatment planning in US cancer care settings","volume":"124","author":"Prabhu Das","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2025.12.021_bib0124","unstructured":"Meet Rosy Inc. Rosy (Version 1.0) [Mobile App]. Dallas, TX: Meet Rosy Inc. Available at: https:\/\/meetrosy.com."},{"key":"10.1016\/j.jmig.2025.12.021_bib0125","article-title":"Pelvic Gym: Pelvic floor education and exercise programs","author":"Pelvic","year":"2025","journal-title":"Pelvic Gym"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465025010003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465025010003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:34:43Z","timestamp":1786059283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465025010003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":125,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1553465025010003"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2025.12.021","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2025.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AAGL. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}